ROYAL MARSDEN CANCER CAMPAIGN TRADING COMPANY LIMITED - Key Persons
Job Titles:
- Chairman of Rightmove Plc
Andrew is Chair of Rightmove plc and Chair of Epidemic Sound as well as a Non-Executive Director of Marks and Spencer Group plc.
He was appointed CEO of Shazam in March 2005 and became Executive Chairman in 2013. During Andrew's tenure Shazam became one of the world's leading mobile brands with over 1 billion users. The company was acquired by Apple in 2018.
Andrew was a member of The Royal Marsden Cancer Charity's Oak Cancer Centre Appeal Board and has been a Non-Executive Director of MoneySuperMarket Group plc and Merlin Entertainments plc as well as a member of the Council of Loughborough University. In 2016 Andrew was awarded an OBE in recognition for his services to the digital economy.
After studying Economics at Cambridge, Antonia worked for management consultants McKinsey & Co and then in the strategy department at Thomson Reuters before moving into the voluntary sector. Positions at Marie Curie, Start Here and Great Ormond Street Hospital Children's Charity followed.
Antonia was at GOSHCC for seven years, before joining us at The Royal Marsden Cancer Charity as our director in 2015.
Anya Hindmarch founded her eponymous business in London in 1987 and has since grown it into a global brand. An advocate of British design and arts, Anya is also a Non-Executive Director of the British Fashion Council and an Emeritus trustee of both the Royal Academy of Arts and the Design Museum. In 2017, Anya was awarded a CBE in recognition for her contribution to the British fashion industry and has received several notable industry awards, including a British Fashion Award.
Job Titles:
- Chief Executive of the Royal Marsden NHS Foundation Trust
Cally is the Chief Executive of The Royal Marsden NHS Foundation Trust. In 2006 she was awarded a CBE for her contribution to healthcare. Cally was appointed NHS National Cancer Dir...
Professor Nicholas van As was appointed Medical Director of The Royal Marsden NHS Foundation Trust in January 2016. He has been a Consultant Clinical Oncologist in the Urology Unit at The Royal Marsden since 2008 and is the hospital's Clinical Lead for stereotactic body radiotherapy (SBRT) and CyberKnife. Nicholas is also a Professor at The Institute of Cancer Research.
Professor van As is Chair of the UK SBRT Consortium and the national clinical lead for NHS England's Commissioning through Evaluation Programme for SBRT. His main research interests are in stereotactic and image-guided radiotherapy, risk prediction in early prostate cancer, and functional MRI, and he has published numerous papers on these subjects and delivered presentations at international meetings. He is the Chief Investigator for the PACE trial - an international, randomised controlled trial comparing SBRT to image-guided radiotherapy (IGRT) and surgery for treating prostate cancer.
Nicole Junkermann is an international entrepreneur and investor, focused on identifying opportunities to disrupt traditional business models through industry-defining technologies.
German born and London based, Nicole has built a deep and diverse business network across Europe, the U.S., and Asia. Fluent in six languages, Nicole has experience living and working across each of these continents. As an entrepreneur turned investor, Nicole has experience sitting at both sides of the investment table and applies this experience and knowledge to the like-minded innovators she invests in. She is a valued and active partner who helps these emerging leaders build their early-stage enterprises into successful companies. As a major investor and Vice-Chairperson of Infront Sports & Media, Nicole helped build the company into a top sports and media rights business, leading it to a successful sale to Bridgepoint Capital in 2011. Nicole also founded United in Sports, her own private equity fund focused on sports and media investments, which raised approximately 250m. Nicole is a Director of NJF Capital portfolio company, Owkin, and currently serves as an Advisor to pan-European private equity firm, Trilantic Europe. Nicole also sits on the Tate Americas Foundation Latin American Acquisitions Committee, supporting the work of Latin American artists. In August 2023, Nicole was appointed a Trustee of the Royal Academy Trust.
Job Titles:
- House of Lords' Spokesperson for Wales
Olivia Bloomfield is the House of Lords' Spokesperson for Wales and a Government whip for three other Ministries. Her career has encompassed executive search, private equity, and energy infrastructure projects. She has been active in the voluntary sector as a magistrate and a founding trustee of three small Oxfordshire based charities. In 2006, she was asked to head up the Conservative Party's fundraising team on behalf of David Cameron and was appointed to the House of Lords in 2016. She joined the front bench in 2019.
Roger Gray studied Philosophy, Politics and Economics at Oxford University and then Economics at Harvard University before embarking on a career in investment management spanning four decades. He began in the asset management business at Rothschild Asset Management where he rose to Chief Investment Officer (CIO), before moving to UBS Asset Management (Switzerland) as CEO and CIO and then Global Head of Asset Allocation/Currency. His later career was spent as CIO for the UK's two largest pension funds, at Hermes for the BT Pension Scheme and then for 10 years at USS Investment Management Ltd on behalf of the Universities Superannuation Scheme.
Roger's portfolio of charitable activities includes the Countess of Munster Musical Trust, the Winchester College Investment Committee and the Triago Advisory Board.
Job Titles:
- Chairman
- Chairman of Both
Sir Douglas Flint is Chairman of both The Royal Marsden Cancer Charity and The Royal Marsden NHS Foundation Trust. He first became a Trustee of The Royal Marsden Cancer Charity in 2017.
Sir Douglas has had two extensive executive careers. At international accounting firm KPMG, he trained as a chartered accountant and became a partner in 1988. He then joined HSBC in September 1995 as Group Finance Director and was appointed Group Chairman of HSBC Holdings plc in 2010, retiring in 2017 after 22 years of service. Over his career, he has gained valuable experience though a varied non-executive director portfolio in both the private and charitable sectors.
In June 2006 Mr Flint was honoured with a CBE and in June 2018 was awarded a Knighthood, both awards in recognition of his services to the finance industry.
Sir Terry Leahy, was appointed Chief Executive of Tesco PLC in March 1997 and retired from this position in March 2011.
He received a Knighthood for services to food retailing in the 2002 New Year Honours and in the same year was made a Freeman of the City of Liverpool and is a member of the Liverpool Enterprise Partnership Advisory Board.
In March 2008 he was nominated by Retail Week as Retail Leader of the Year. From 2005 to 2010 he was voted as Britain's Most Admired Leader by Management Today and in 2004 he was named European Businessman of the year by Fortune Magazine. In 2010 he received the Daily Telegraph's Award for a Decade of Excellence in Business a Lifetime Achievement award from Director Magazine and was voted Business Person of the Year by the Sunday Times.
Terry is now a senior advisor to Clayton Dubilier & Rice, the US private equity firm and holds various Chair and Executive Committee memberships - including chairman of the board for Morrisons and Mobilux.
Varun joined Hakluyt in 2014 and serves as the company's Managing Partner. Prior to joining Hakluyt, Varun worked in investment and merchant banking, advising on M and A, private equity investments, and business development.
Initially trained at Lehman Brothers, he went on to help build a regulated advisory firm for former UK Prime Minister Tony Blair, where he was responsible for transactions typically involving sovereign wealth and emerging markets businesses. He has also co-founded a merchant bank with a private family investment company; advised a former UK foreign secretary on business and economic issues; and invested in a number of early-stage companies.
He sits on various charitable and commercial boards, including Sesame Workshop, the world's leading early learning media platform, IP Group, Inc (an early-stage technology investment firm based in the US) and the Marylebone Cricket Club Foundation. Varun is also an Impact Director for Yaletown Partners (a venture and growth capital fund based in Canada), and a Trustee of the Royal Academy Trust.